It can be very difficult to keep up with the latest cannabis news since there seems to be so much lately. This is a great problem to have, and now we have a solution! Here, we’ve compiled a list of 5 of the most important cannabis news stories this week.
1. Campaign for Limited Social Use in Denver Submits Signatures for November Ballot
Members of the Denver campaign for Limited Social Cannabis Use submitted approximately 10,700 signatures to the Denver Elections Division, beating the initial goal of 10,000. Just more than 4,700 of the submitted signatures must be verified by September 4 in order for the initiative to appear on the ballot for City and County of Denver residents in November.
2. Cannabis Credit Union Sues Federal Government
A Colorado-based credit union for cannabis businesses filed lawsuits against the Federal Reserve of Kansas City and the National Credit Union Administration. After gaining support from state regulators, the Fourth Corner Credit Union’s application for federal approval was rejected. The NCUA’s decision came after more than 6 months of waiting, moving the battle from the hands of federal bureaucrats to the federal court system.
3. Cannabis Labor Union Official Indicted after FBI Investigation
The former head of the Cannabis Division of the United Food and Commercial Workers Union was indicted in federal court after a joint investigation by the Department of Justice and Federal Bureau of Investigation. The union official, identified as Dan Rush, is charged with ‘Labor union conflict of interest’ and fraud. He is alleged to have borrowed a six-figure of money, and offered to use union influence to repay the debt.
4. ResponsibleOhio set to go to Court over Ballot Phrasing
ResponsibleOhio, the group backing legalization in the Buckeye State, has stated it will take its issues with the phrasing of the ballot initiative to the Ohio Supreme Court. Representatives from the group believe the current ballot wording is biased in favor of prohibitionists. Ohioans will decide the fate of the controversial legalization initiative in the November election.
5. FDA Approves Oxycontin for 11-year old Children
The U.S. Food and Drug Administration approved use of the potent painkiller for children as young as 11. This controversial decision comes as national debate heats up surrounding cannabis’s scheduling status with the federal government. Currently, cannabis is a Schedule 1 drug, meaning it has “no currently accepted medical use and a high potential for abuse”, while oxycontin is a Schedule 2 drug.